- November 4, 2016
- 7:00 pm
California Institute of Integral Studies
1453 Mission Street,
San Francisco, CA 94103
FDA-approved clinical trials at Johns Hopkins University and NYU School of Medicine have evaluated the effects of a psilocybin-facilitated mystical experience with diverse populations including individuals diagnosed with cancer experiencing psycho-spiritual and existential distress-many of these patients at the end of life. Subjective features of a mystical experience include unity, sacredness, transcendence, and a greater connection to deeply felt positive emotions including that of love.
This evening presentation and panel discussion explores the prominent, meaning-making, and transformative experiences of love and agape (spiritual, transcendent, or highest form of selfless love) that frequently emerge in psilocybin sessions. The panel discussion includes background information on psilocybin research and clinical case vignettes on the emergence of love within the psilocybin-facilitated mystical experience and its role in cultivating compassion and promoting healing. This event includes time for panel question and answer period moderated by Janis Phelps, Director of the Center for Psychedelic Therapies and Research.
This event is an educational program of the CIIS Center for Psychedelic Therapies and Research in collaboration with CIIS Public Programs & Performances.
Mary Cosimano, MSW, is currently with the Department of Psychiatry and Behavioral Sciences at the Johns Hopkins University School of Medicine. Mary has served as study guide and research coordinator for the psilocybin studies for over 15 years. During that time she has been a lead session guide for six psilocybin studies and has conducted over 350 sessions. She has trained post doctorate fellows, research assistants and interns as assistant guides. She has administered the psychological evaluations for psilocybin studies as well as many other studies in our Behavioral Biology Research Unit. Ms. Cosimano has 15 years of experience with direct patient care as a hospice volunteer. In addition to her work with the psilocybin studies, she has been involved in the Salvia Divinorum, Dextromethorphan, and Club Drug studies conducted at Johns Hopkins.
Anthony P. Bossis, PhD, is a clinical psychologist and Clinical Assistant Professor of Psychiatry at New York University School of Medicine. He is director of palliative care research, co-principal investigator, and a session guide for the NYU Psilocybin Cancer Anxiety Study, a FDA-approved clinical trial investigating the efficacy of a psilocybin-generated mystical experience upon the existential and psycho-spiritual distress in persons with cancer. He is also Lead Investigator and the primary session guide for the NYU Psilocybin Religious Leaders Study, an FDA-approved clinical trial evaluating the effects of a psilocybin-facilitated mystical experience upon religious leaders. Dr. Bossis is the co-founder and former Co-Director of the Palliative Care Service and a clinical supervisor of psychotherapy at Bellevue Hospital. He has a long-standing interest in comparative religion, consciousness research, and the interface of psychology and spirituality. He maintains a private psychotherapy practice in NYC.